diabetes mellitus Clinical Trials and Research
Also known as: diabetes, sugar diabetes, dm, type 1 diabetes, type 2 diabetes, gestational diabetes, insulin resistance · ICD-10: E10-E13
Diabetes mellitus is a condition where the body struggles to manage blood sugar levels, often due to issues with insulin. Clinical trial research is actively exploring new ways to prevent, treat, and manage diabetes and its complications. Find a Trial helps patients search for active studies.
Search diabetes mellitus trials →
Common questions about diabetes mellitus clinical trials
What are clinical trials for diabetes?
Clinical trials for diabetes are research studies that test new ways to prevent, detect, or treat the condition. They evaluate new medications, devices, lifestyle interventions, or surgical procedures. Data from ClinicalTrials.gov and NIH RePORTER show ongoing efforts to improve patient care.
Who can participate in diabetes clinical trials?
Eligibility criteria vary for each study, often based on the type of diabetes, age, overall health, and specific medical history. Researchers use these criteria to ensure patient safety and collect relevant data. Patients can review study details on platforms like Find a Trial.
What are the different phases of diabetes clinical trials?
Clinical trials typically progress through phases: Phase 1 tests safety, Phase 2 evaluates effectiveness and side effects, and Phase 3 compares new treatments to existing ones. Phase 4 studies monitor long-term safety and efficacy after approval. This structured approach ensures thorough evaluation.
Do diabetes clinical trials cost money to participate?
Most clinical trials do not charge participants for study-related care, and some may even cover travel or provide stipends. However, standard medical care costs not related to the study are usually the participant's responsibility. Details are outlined in the informed consent.
What types of interventions are being studied for diabetes?
Research for diabetes interventions includes new medications to improve insulin production or sensitivity, advanced glucose monitoring devices, and innovative insulin delivery systems. Lifestyle interventions, such as diet and exercise programs, are also frequently studied.
What are common research directions for diabetes treatments?
Current research directions for diabetes treatments, as seen on ClinicalTrials.gov and NIH RePORTER, focus on preventing type 1 diabetes, developing more effective and safer drugs for type 2, and finding cures. Studies also explore managing complications like kidney disease and neuropathy.
Are there specific biomarkers important in diabetes clinical trials?
Yes, important biomarkers in diabetes clinical trials include blood glucose levels, HbA1c (glycated hemoglobin), insulin levels, and C-peptide. Researchers also study markers related to inflammation, kidney function, and cardiovascular health to assess treatment impact and disease progression.
What might exclude someone from a diabetes clinical trial?
Common exclusion criteria for diabetes trials might include uncontrolled co-existing medical conditions, severe complications, pregnancy, or use of certain medications that could interfere with the study drug. Each trial has specific criteria to ensure safety and data integrity.
How to find a diabetes mellitus trial that fits you
- Describe your diabetes mellitus situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all diabetes mellitus trials →